Ticker Scorecard - FENC Basics Company: Fennec Pharmaceuticals Inc. IPO Date: September 11, 2017 Sector: Healthcare Industry: Biotech Market Cap: $182.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.49% Avg Daily Range (30 D): $0.11 | 1.72% Avg Daily Range (90 D): $0.15 | 2.85% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 132 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 31 Avg Inst. Trade: $3.14M Avg Inst. Trade (30 D): $3.23M Avg Inst. Trade (90 D): $3.23M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.7M Avg Closing Trade (30 D): $3.23M Avg Closing Trade (90 D): $3.23M Avg Closing Volume: 817.09K     News Feb 7, 2025 @ 12:00 PM Fennec Pharmaceuticals Announces Commercial Launch... Source: Fennec Pharmaceuticals Inc. Jul 1, 2024 @ 10:00 AM Fennec Pharmaceuticals Announces Management Change... Source: Fennec Pharmaceuticals Inc. Jun 25, 2024 @ 8:35 PM Fennec Announces Results of Annual Meeting Source: Fennec Pharmaceuticals Inc. May 14, 2024 @ 11:15 AM Adherex Technologies Inc. (FENC) Lags Q1 Earnings ... Source: Zacks Equity Research May 14, 2024 @ 10:03 AM Fennec Pharmaceuticals Reports First Quarter 2024 ... Source: Fennec Pharmaceuticals Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.04 $-.21 $-.2 Diluted EPS $-.04 $-.21 $-.2 Revenue $ 49.35M $ 6.97M $ 7.26M Gross Profit $ $ $ Net Income / Loss $ -1.13M $ -5.74M $ -5.55M Operating Income / Loss $ 1.68M $ -5.2M $ -5.04M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Sep 05, 2014:   3:1 Aug 30, 2011:   18:1 Aug 02, 2005:   5:1